'A common problem': Oura delays its IPO
Oura postponed its IPO due to market uncertainty, despite strong demand. The company aims to raise $2.2B by selling 50M shares at $40-$44 each. Oura reported $1.2B revenue and a $924M net loss for the nine months ending June 30. Experts cite valuation concerns and macroeconomic volatility as factors. The company competes with Fitbit and Apple Watch in the health-tracking wearables market.
How this was made
The 30-second read
Why it matters
The delay reflects heightened market volatility and may dampen short‑term sentiment for upcoming tech IPOs.
Market read
IPO market uncertainty could affect other growth‑stage tech listings.
What to watch
Oura's subscription base growth may still support a future IPO.
Background
Oura, a Finnish health‑tracking ring maker, announced postponement of its planned Nasdaq IPO.
Market effects
Potential slowdown in IPO activity for health‑tech wearables.
European tech IPO pipeline may face added scrutiny.
Signals broader market caution amid rising yields.
Counterpoint
Delay could preserve valuation and attract better pricing later.
Key entities
- companyOura
Health‑tracking wearable maker planning an IPO.




